Multiplikator Forward P/S: electroCore Inc (ECOR)
electroCore, Inc. (ECOR) generates revenue through the sale of gammaCore activation cards, ensuring stable FCF. The projected revenue multiple provided by GURU.Markets confirms the stability of the metrics, where the parameter value equals 1.30. Business growth relies on physician recognition of neurostimulation systems and the control of marketing expenses. Ultimate success depends on the expansion of insurance reimbursements and the transition of patients to hardware therapy.
Ringkesan rincian data analitis electrocore.com (ECOR)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal electroCore, Inc.|ECOR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal electroCore|ECOR - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ECOR|ECOR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan electroCore|Rasio cepet electrocore.com
- rincian asil keuangan lan kelipatan valuasi:
ECOR - Penghasilan resik perusahaan|Bathi sing dikarepake electroCore, Inc.|ECOR - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi electroCore|ECOR - Pangali PEG|Pangali EV/EBITDA ECOR|ECOR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan electroCore|ECOR - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan electrocore.com|ECOR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep electroCore, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:ECOR (electroCore Medical)
The investment attractiveness of electroCore, Inc. (ECOR) is based on the exclusivity of its neurostimulation patents and stringent FDA regulatory control. The forward P/S ratio correlates current market capitalization with expected annual revenue, reflecting market expectations for the commercialization of medtech. Analyzing this metric allows for an assessment of whether the premium for the technological barrier is justified by the business's future cash flows.
Karo sapa electroCore, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep profusa.com (PFSA)|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|Rasio rega marang prakiraan pendapatan GCTK|Multiplikator Forward P/S NAOV|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD - Multiplikator forward rega marang pendapatan|ASXC: Multiplikator forward rega marang pendapatan|Avinger Inc. - Rasio rega marang pendapatan sing dikarepake|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Cutera Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep inarimedical.com NARI|Multiplikator Forward P/S NVRO|Multiplikator forward rega marang pendapatan reshapelifesciences.com RSLS|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
